Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Zahnarztliche Mitteilungen
|
December 16, 1988
[Teeth of Bavarians]
H Kluger, W Wiedemann
Die Quintessenz Der Zahntechnik
|
June 1, 1983
[Amelogenesis imperfecta--clinical and technical rehabilitation is not an everyday occurrence]
H Kluger, L Haake, W Peetz
Advances in Experimental Medicine and Biology
|
January 1, 1989
The influence of Oxindanac on kallikrein metabolism
W Gross, U Sinterhauf, S Gross, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
February 16, 2008
Role of haptoglobin on the uptake of native and beta-chain [trimesoyl-(Lys82)beta-(Lys82)beta] cross-linked human hemoglobins in isolated perfused rat livers
Edwin C Y Chow, Lichuan Liu, Noam Ship, et al.
Journal of the American Academy of Dermatology
|
October 14, 2014
Clinical characteristics associated with Spitz nevi and Spitzoid malignant melanomas: the Yale University Spitzoid Neoplasm Repository experience, 1991 to 2008
Jason P Lott, Jade Wititsuwannakul, Julie J Lee, et al.
ESMO Open
|
April 21, 2026
Compartment-specific immune and tumor markers associated with clinical outcomes in patients with and without sarcomatoid/rhabdoid renal cell carcinoma treated with ipilimumab and nivolumab
N Savion-Gaiger, O Perales, D G Su, et al.
Oncogene
|
September 17, 2013
Genetic inactivation or pharmacological inhibition of Pdk1 delays development and inhibits metastasis of Braf(V600E)::Pten(-/-) melanoma
M Scortegagna, C Ruller, Y Feng, et al.
Journal of Cutaneous Pathology
|
November 8, 2019
Histopathology-guided mass spectrometry differentiates benign nevi from malignant melanoma
Rossitza Lazova, Katy Smoot, Heather Anderson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 9, 2017
Changes in serum interleukin-8 (IL-8) levels reflect and predict response to anti-PD-1 treatment in melanoma and non-small-cell lung cancer patients
M F Sanmamed, J L Perez-Gracia, K A Schalper, et al.
ESMO Open
|
December 6, 2024
Nivolumab plus relatlimab and nivolumab plus ipilimumab for patients with advanced renal cell carcinoma: results from the open-label, randomised, phase II FRACTION-RCC trial
T K Choueiri, T M Kuzel, S S Tykodi, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Zahnarztliche Mitteilungen
|
December 16, 1988
[Teeth of Bavarians]
H Kluger, W Wiedemann
Die Quintessenz Der Zahntechnik
|
June 1, 1983
[Amelogenesis imperfecta--clinical and technical rehabilitation is not an everyday occurrence]
H Kluger, L Haake, W Peetz
Advances in Experimental Medicine and Biology
|
January 1, 1989
The influence of Oxindanac on kallikrein metabolism
W Gross, U Sinterhauf, S Gross, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
February 16, 2008
Role of haptoglobin on the uptake of native and beta-chain [trimesoyl-(Lys82)beta-(Lys82)beta] cross-linked human hemoglobins in isolated perfused rat livers
Edwin C Y Chow, Lichuan Liu, Noam Ship, et al.
Journal of the American Academy of Dermatology
|
October 14, 2014
Clinical characteristics associated with Spitz nevi and Spitzoid malignant melanomas: the Yale University Spitzoid Neoplasm Repository experience, 1991 to 2008
Jason P Lott, Jade Wititsuwannakul, Julie J Lee, et al.
ESMO Open
|
April 21, 2026
Compartment-specific immune and tumor markers associated with clinical outcomes in patients with and without sarcomatoid/rhabdoid renal cell carcinoma treated with ipilimumab and nivolumab
N Savion-Gaiger, O Perales, D G Su, et al.
Oncogene
|
September 17, 2013
Genetic inactivation or pharmacological inhibition of Pdk1 delays development and inhibits metastasis of Braf(V600E)::Pten(-/-) melanoma
M Scortegagna, C Ruller, Y Feng, et al.
Journal of Cutaneous Pathology
|
November 8, 2019
Histopathology-guided mass spectrometry differentiates benign nevi from malignant melanoma
Rossitza Lazova, Katy Smoot, Heather Anderson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 9, 2017
Changes in serum interleukin-8 (IL-8) levels reflect and predict response to anti-PD-1 treatment in melanoma and non-small-cell lung cancer patients
M F Sanmamed, J L Perez-Gracia, K A Schalper, et al.
ESMO Open
|
December 6, 2024
Nivolumab plus relatlimab and nivolumab plus ipilimumab for patients with advanced renal cell carcinoma: results from the open-label, randomised, phase II FRACTION-RCC trial
T K Choueiri, T M Kuzel, S S Tykodi, et al.
Page
of 2